October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Amy C. Moore: Global biomarker testing survey focused on patients and caregivers diagnosed with NSCLC
Sep 14, 2024, 17:39

Amy C. Moore: Global biomarker testing survey focused on patients and caregivers diagnosed with NSCLC

Amy C. Moore shared post by Precision Oncology Connect on X:

“For those attending ESMO24, be sure to check out our poster on our global biomarker testing survey focused on patients and caregivers diagnosed with NSCLC in the past 5 years by Dr. Antonio Calles, Christian Rolfo, Shani Shilo, Dr Anne-Marie Baird, Abdelali (Ali) Majdi and Bayer AG.”

Quoting Precision Oncology Connect’s post:

“Visit this poster at ESMO24Assessing Biomarker Testing Awareness Among Patients and Caregivers in NSCLC Through an Interdisciplinary Global Survey’ 204p.

  • Sunday 15th Sept
  • 12.00-13.00h
  • CEST, Hall 6.”

Source: Amy C. Moore/X and Precision Oncology Connect/X

Dr. Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.